Cargando…

Sildenafil, a phosphodiesterase type 5 inhibitor, augments sphincter bursting and bladder afferent activity to enhance storage function and voiding efficiency in mice

OBJECTIVES: To investigate the influence of low‐dose sildenafil, a phosphodiesterase type 5 inhibitor (PDE5‐I), on the function of the mouse lower urinary tract (LUT). MATERIALS AND METHODS: Adult male mice were decerebrated and arterially perfused with a carbogenated Ringer's solution to estab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ito, Hiroki, Chakrabarty, Basu, Drake, Marcus J., Fry, Christopher H., Kanai, Anthony J., Pickering, Anthony E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Translational Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579678/ https://www.ncbi.nlm.nih.gov/pubmed/30636087 http://dx.doi.org/10.1111/bju.14664

Ejemplares similares

Influence of sildenafil on the purinergic components of nerve‐mediated and urothelial ATP release from the bladder of normal and spinal cord injured mice
por: Chakrabarty, Basu, et al.
Publicado: (2019)

Selective reduction of neurotransmitter release by cAMP-dependent pathways in mouse detrusor
por: Chakrabarty, Basu, et al.
Publicado: (2022)

Modulation of Bladder Wall Micromotions Alters Intravesical Pressure Activity in the Isolated Bladder
por: Chakrabarty, Basu, et al.
Publicado: (2019)

Use of sildenafil or other phosphodiesterase inhibitors and risk of melanoma
por: Pottegård, Anton, et al.
Publicado: (2016)

Characterization of mouse neuro‐urological dynamics in a novel decerebrate arterially perfused mouse (DAPM) preparation
por: Ito, Hiroki, et al.
Publicado: (2018)

Muro-Neuro-Urodynamics; a Review of the Functional Assessment of Mouse Lower Urinary Tract Function
por: Ito, Hiroki, et al.
Publicado: (2017)

Botulinun A toxin urethral sphincter injection for neurogenic or nonneurogenic voiding dysfunction
por: Kuo, Hann-Chorng
Publicado: (2016)

Probabilistic, spinally-gated control of bladder pressure and autonomous micturition by Barrington’s nucleus CRH neurons
por: Ito, Hiroki, et al.
Publicado: (2020)

Therapeutic Effects of Botulinum Toxin A, via Urethral Sphincter Injection on Voiding Dysfunction Due to Different Bladder and Urethral Sphincter Dysfunctions
por: Lee, Yu-Khun, et al.
Publicado: (2019)

Internal anal sphincter augmentation and substitution
por: de la Portilla, Fernando
Publicado: (2014)

Phosphodiesterase Inhibitors Sildenafil and Vardenafil Reduce Zebrafish Rod Photoreceptor Outer Segment Shedding
por: Campbell, Leah J., et al.
Publicado: (2017)

Biphasic Effect of Sildenafil on Energy Sensing is Mediated by Phosphodiesterases 2 and 3 in Adipocytes and Hepatocytes
por: Banerjee, Jheelam, et al.
Publicado: (2019)

An animal study to compare the degree of the suppressive effects on the afferent pathways of micturition between tamsulosin and sildenafil
por: Kim, Sung-Eun, et al.
Publicado: (2013)

Voided Urinary Microbiota Is Stable Over Time but Impacted by Post Void Storage
por: Bundgaard-Nielsen, Caspar, et al.
Publicado: (2020)

The Therapeutic Effects and Pathophysiology of Botulinum Toxin A on Voiding Dysfunction Due to Urethral Sphincter Dysfunction
por: Kao, Yao-Lin, et al.
Publicado: (2019)

Anal Sphincter Augmentation Using Biological Material
por: Alam, Nasra N., et al.
Publicado: (2015)

Magnetic Sphincter Augmentation After Gastric Surgery
por: Riva, Carlo Galdino, et al.
Publicado: (2019)

The Frequency-Dependence of Pre- and Postganglionic Nerve Stimulation of Pig and Rat Bladder
por: Kitney, Darryl, et al.
Publicado: (2021)

Sildenafil, a Phosphodiesterase Type 5 Inhibitor, Downregulates Osteopontin in Human Peripheral Blood Mononuclear Cells
por: Kaleta, Beata, et al.
Publicado: (2017)

Effect of the Phosphodiesterase 5 Inhibitor Sildenafil on Ischemia-Reperfusion-Induced Muscle Mitochondrial Dysfunction and Oxidative Stress
por: Tetsi, Liliane, et al.
Publicado: (2019)

Role of voiding and storage symptoms for the quality of life before and after treatment in men with voiding dysfunction
por: Sountoulides, Petros, et al.
Publicado: (2009)

Differential Regulation of Bladder Pain and Voiding Function by Sensory Afferent Populations Revealed by Selective Optogenetic Activation
por: DeBerry, Jennifer J., et al.
Publicado: (2018)

Voiding Dysfunction in Old Male Rats Associated With Enlarged Prostate and Irregular Afferent-Triggered Reflex Responses
por: Zhang, Chuan, et al.
Publicado: (2020)

Results of Magnetic Sphincter Augmentation for Gastroesophageal Reflux Disease
por: Schwameis, Katrin, et al.
Publicado: (2018)

Severe Dysphagia is Rare After Magnetic Sphincter Augmentation
por: Bologheanu, Milena, et al.
Publicado: (2022)

The Potential Role of Sildenafil in Cancer Management through EPR Augmentation
por: Haider, Mohamed, et al.
Publicado: (2021)

Combination phosphodiesterase type 4 inhibitor and phosphodiesterase type 5 inhibitor treatment reduces non-voiding contraction in a rat model of overactive bladder
por: Balog, Brian M., et al.
Publicado: (2019)

Needs and Expectations of Patients with Erectile Dysfunction: An Update on Pharmacological Innovations in Phosphodiesterase Type 5 Inhibition with Focus on Sildenafil
por: Jannini, Emmanuele A., et al.
Publicado: (2018)

The phosphodiesterase 5 inhibitor sildenafil decreases the proinflammatory chemokine IL-8 in diabetic cardiomyopathy: in vivo and in vitro evidence
por: Giannattasio, S., et al.
Publicado: (2018)

Sildenafil, a phosphodiesterase-5 inhibitor, stimulates angiogenesis and bone regeneration in an atrophic non-union model in mice
por: Menger, Maximilian M., et al.
Publicado: (2023)

Phosphodiesterase 5 (PDE-5) inhibitors (sildenafil, tadalafil, and vardenafil) effects on esophageal motility: a systematic review
por: Shafiee, Arman, et al.
Publicado: (2023)

Phosphodiesterase 8 governs cAMP/PKA-dependent reduction of L-type calcium current in human atrial fibrillation: a novel arrhythmogenic mechanism
por: Grammatika Pavlidou, Nefeli, et al.
Publicado: (2023)

Magnetic Sphincter Augmentation Outcomes in Severe Gastroesophageal Reflux Disease
por: Ferrari, Davide, et al.
Publicado: (2021)

Complete endoscopic removal of an eroded magnetic sphincter augmentation device
por: Mahmoud, Tala, et al.
Publicado: (2021)

The role of magnetic sphincter augmentation in the treatment of gastroesophageal reflux disease
por: Bonavina, Luigi, et al.
Publicado: (2021)

Management of sphincter insufficiency in patients with neurogenic bladder and bladder augmentation
por: Taskinen, Seppo, et al.
Publicado: (2023)

Safety profile of magnetic sphincter augmentation for gastroesophageal reflux disease
por: Froiio, Caterina, et al.
Publicado: (2023)

Real-World Data Regarding Satisfaction to Botulinum Toxin A Injection into the Urethral Sphincter and Further Bladder Management for Voiding Dysfunction among Patients with Spinal Cord Injury and Voiding Dysfunction
por: Lee, Cheng-Ling, et al.
Publicado: (2022)

The Utility of Post-Void Residual Volume versus Sphincter Electromyography to Distinguish between Multiple System Atrophy and Parkinson’s Disease
por: Yamamoto, Tatsuya, et al.
Publicado: (2017)

Sildenafil, a phosphodiesterase type 5 inhibitor, enhances the antidepressant activity of amitriptyline but not desipramine, in the forced swim test in mice
por: Socała, Katarzyna, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_98ug47f7gdrnn17clua2gc5f64